Valuation: Stille AB

Market Cap 2.28B 230M 205M 190M 173M 324M 21.8B 329M 896M 11.4B 863M 845M 36.43B P/E 2026 *
27.3x
P/E 2027 * 20.9x
Enterprise Value 2.22B 224M 200M 185M 168M 316M 21.23B 321M 872M 11.1B 840M 823M 35.47B EV / Sales 2026 *
3.04x
EV / Sales 2027 * 2.66x
Free-Float
53.19%
Yield 2026 *
-
Yield 2027 * 0.79%
1 day+0.59%
1 week+3.66%
Current month+3.24%
1 month+0.99%
3 months+2.41%
6 months+19.44%
Current year+30.10%
1 week 242
Extreme 242
258.5
1 month 241.5
Extreme 241.5
260
Current year 143
Extreme 143
283
1 year 143
Extreme 143
283
3 years 94.2
Extreme 94.2
283
5 years 94.2
Extreme 94.2
283
10 years 37.5
Extreme 37.5
283
Manager TitleAgeSince
Chief Executive Officer 48 12/05/2025
Director of Finance/CFO 54 08/12/2025
Chief Operating Officer - 02/01/2026
Director TitleAgeSince
Chairman 70 07/05/2025
Director/Board Member 66 01/01/2000
Director/Board Member 63 01/01/2021
Date Insider Type Main position Quantity % Market Cap. Importance
5/27/26 A Buy

Chief Operating Officer

1,197 0.0133%
4/30/26 A Sell 8,049 0.0896%
3/10/26 A Sell

Director

2,750 0.0306%
Change 5-day change 1-year change 3-year change Capi.($)
+0.59%+3.66%+31.44%+160.20% 230M
-0.79%+2.20%-19.04%+9.03% 180B
-2.09%+0.91%-3.14%+28.22% 114B
+1.11%+5.43%-20.43%+11.00% 114B
+0.30%+4.20%-51.43%-6.51% 78.39B
-0.27%+4.60%+4.72%+79.05% 64.88B
+1.60%+2.67%+15.08%+77.83% 54.02B
-0.53%+0.98%+0.87%-25.92% 51.96B
-0.81%+6.08%-12.53%+30.57% 43.79B
-0.07%+0.07%+29.10%-0.07% 32.45B
Average -0.10%+2.82%-2.54%+36.34% 73.36B
Weighted average by Cap. -0.31%+2.97%-11.70%+20.36%

Financials

2026 *2027 *
Net sales 729M 73.64M 65.64M 60.81M 55.29M 104M 6.98B 105M 287M 3.65B 276M 271M 11.67B 803M 81.03M 72.23M 66.91M 60.84M 114M 7.68B 116M 316M 4.02B 304M 298M 12.84B
Net income 83.57M 8.44M 7.52M 6.97M 6.33M 11.89M 800M 12.08M 32.86M 418M 31.66M 31M 1.34B 109M 11.02M 9.82M 9.1M 8.27M 15.52M 1.04B 15.78M 42.91M 546M 41.34M 40.47M 1.75B
Net Debt -59.81M -6.04M -5.38M -4.99M -4.53M -8.51M -573M -8.65M -23.52M -299M -22.66M -22.18M -957M -146M -14.77M -13.17M -12.2M -11.09M -20.81M -1.4B -21.15M -57.53M -732M -55.42M -54.26M -2.34B
Projected Income Statement - Annual - Stille AB
Logo Stille AB
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Employees
225
Date Price Change Volume
20/10/26 SEK 255.00 +0.59% 12,567
19/10/26 SEK 253.50 -0.39% 2,568
16/10/26 SEK 254.50 +3.67% 55,432
15/10/26 SEK 245.50 +0.41% 6,338
14/10/26 SEK 244.50 -0.61% 2,359
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Stille AB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
253.50SEK
Average target price
287.00SEK
Spread / Average Target
+13.21%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Stille AB
  1. Stock Market
  2. Stocks
  3. STIL Stock